HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahboob U Rahman Selected Research

golimumab

1/2014Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation.
1/2014Effect of golimumab on carotid atherosclerotic disease measures and cardiovascular events in inflammatory arthritides.
10/2013The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
7/2013Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
2/2013Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials.
8/2012Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
7/2012Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
6/2012Effect of golimumab on patient-reported outcomes in rheumatoid arthritis: results from the GO-FORWARD study.
12/2011Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.
11/2011Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahboob U Rahman Research Topics

Disease

32Rheumatoid Arthritis
09/2017 - 12/2004
9Ankylosing Spondylitis
08/2014 - 01/2007
7Inflammation (Inflammations)
08/2014 - 11/2011
7Psoriatic Arthritis
01/2014 - 01/2007
4Giant Cell Arteritis (Horton Disease)
03/2014 - 05/2007
4Necrosis
01/2014 - 03/2007
4Infections
02/2013 - 04/2006
3Tuberculosis (Tuberculoses)
03/2014 - 02/2006
3Anemia
10/2009 - 11/2007
2Arthritis (Polyarthritis)
01/2014 - 02/2013
2Fatigue
06/2012 - 08/2009
2Osteitis
12/2011 - 11/2011
2Synovitis
12/2011 - 11/2011
1Low Back Pain (Lumbago)
01/2016
1Non-Radiographic Axial Spondyloarthritis
01/2016
1Back Pain (Backache)
01/2016
1Sacroiliitis
08/2014
1Axial Spondyloarthritis
08/2014
1Cardiovascular Diseases (Cardiovascular Disease)
01/2014
1Carotid Artery Diseases
01/2014
1Autoimmune Diseases (Autoimmune Disease)
09/2013
1Latent Tuberculosis
07/2012
1Chronic Disease (Chronic Diseases)
06/2012
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
09/2010
1Asthenopia (Eyestrain)
08/2009
1Body Weight (Weight, Body)
05/2007
1Rheumatic Diseases (Rheumatism)
01/2007
1Asthma (Bronchial Asthma)
02/2006
1Emphysema
02/2006
1Bronchitis
02/2006
1Meniere Disease (Menieres Disease)
06/2005
1Hearing Loss (Hearing Impairment)
06/2005
1Osteoarthritis
12/2004
1Carcinoma (Carcinomatosis)
12/2004

Drug/Important Bio-Agent (IBA)

23golimumabFDA Link
01/2014 - 03/2007
15Methotrexate (Mexate)FDA LinkGeneric
09/2017 - 04/2008
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2014 - 03/2007
8Infliximab (Remicade)FDA Link
01/2017 - 04/2006
7Monoclonal AntibodiesIBA
01/2014 - 03/2007
5Etanercept (Enbrel)FDA Link
09/2017 - 06/2005
5C-Reactive ProteinIBA
01/2016 - 08/2009
5Biomarkers (Surrogate Marker)IBA
03/2014 - 07/2009
3Pharmaceutical PreparationsIBA
01/2017 - 08/2014
3GlucocorticoidsIBA
09/2013 - 02/2006
3Hemoglobins (Hemoglobin)IBA
10/2009 - 11/2007
2Antirheumatic Agents (DMARD)IBA
09/2017 - 01/2008
2Adalimumab (Humira)FDA Link
01/2017 - 01/2017
2AntibodiesIBA
01/2017 - 01/2017
2HLA-B27 Antigen (HLA B27 Antigen)IBA
08/2014 - 06/2011
1Biological ProductsIBA
09/2017
1Tumor Necrosis Factor InhibitorsIBA
01/2017
1O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
01/2016
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2014
1matrigelIBA
03/2014
1LipidsIBA
01/2014
1Ferritins (Ferritin)IBA
10/2013
1Interleukin-17 (Interleukin 17)IBA
09/2013
1Alanine Transaminase (SGPT)IBA
02/2013
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2013
1Tuberculin (PPD)IBA
07/2012
1InterferonsIBA
07/2012
1ametantrone (HAQ)IBA
06/2012
1Interleukin-6 (Interleukin 6)IBA
08/2009
1E-SelectinIBA
07/2009
1Interleukin-18 (Interleukin 18)IBA
07/2009
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
07/2009
1Serum Amyloid A Protein (Serum Amyloid A)IBA
07/2009
1antineoplaston A10 (A 10)IBA
04/2006
1ORALIT (ORS)IBA
02/2006
1Prednisone (Sone)FDA LinkGeneric
06/2005
1Matrix Metalloproteinases (MMPs)IBA
12/2004
1EndopeptidasesIBA
12/2004
1Matrix Metalloproteinase 13IBA
12/2004

Therapy/Procedure

15Therapeutics
09/2017 - 06/2005
3Aftercare (After-Treatment)
07/2013 - 07/2009
2Subcutaneous Injections
07/2009 - 06/2005
1Activities of Daily Living (ADL)
01/2017
1Biological Therapy
06/2010